Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Hematology/Oncology Clinics of North America|July 24, 2004
Interferon therapy in chronic myelogenous leukemiaFrançois Guilhot, Lydia Roy, Joëlle Guilhot, et al.Nuclear Medicine Communications|October 7, 2008
Influence of temperature on the radiochemical purity of 99mTc-colloidal rhenium sulfide for use in sentinel node localizationLyza Bensimhon, Thierry Métayé, Joëlle Guilhot, et al.The Journal of Clinical Endocrinology and Metabolism|July 11, 2002
Expression and activity of g protein-coupled receptor kinases in differentiated thyroid carcinomaThierry Métayé, Emmanuelle Menet, Joëlle Guilhot, et al.Cancer|October 28, 2014
Analyzing molecular response in chronic myeloid leukemia clinical trials: pitfalls and golden rulesJoëlle Guilhot, Claude Preudhomme, Francois Xavier Mahon, et al.Best Practice & Research. Clinical Haematology|December 5, 2009
Interferon in chronic myeloid leukaemia: past and futureFrançois Guilhot, Lydia Roy, Pierre-Jean Saulnier, et al.Clinical Lymphoma & Myeloma|March 27, 2007
Immunotherapy in chronic myelogenous leukemiaFrançois Guilhot, Lydia Roy, Geraldine Martineua, et al.Journal of Nuclear Medicine Technology|August 9, 2012
The presence of sodium nitrate in generator eluate decreases the radiochemical purity of 99mTc-sestamibiThierry Métayé, Thierry Rosenberg, Joëlle Guilhot, et al.Haematologica|March 16, 2012
Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trialsMin Tang, Jasmine Foo, Mithat Gönen, et al.Haematologica|January 12, 2005
Factors predicting molecular and cytogenetic response in chronic myeloid leukemia patients treated with imatinibCatherine Roche-Lestienne, Stéphane Darré, Jean-Luc Laï, et al.Leukemia & Lymphoma|April 10, 2008
Immunotherapeutic approaches in chronic myelogenous leukemiaFrançois Guilhot, Lydia Roy, Pierre-Jean Saulnier, et al.Pageof 5